Skip to main content

Table 1 Baseline characteristics of 267 HIV-seropositive active illicit drug users including physician experience

From: Physician experience and rates of plasma HIV-1 RNA suppression among illicit drug users: an observational study

Characteristic

All (267)

Physician experience

p-value

 

n (%)

Median (IQR3)

 

Gender

   

   Male

143 (53.6)

41 (13-98)

0.434

   Female

124 (46.4)

48 (13-130)

 

Aboriginal ancestry

   

   No

162 (60.7)

55 (15-103)

0.716

   Yes

105 (39.3)

42 (10-116)

 

DTES residence

   

   No

83 (31.1)

28 (8-92)

0.018

   Yes

184 (68.9)

56 (16-123)

 

ART adherence

   

   ≤ 95% in first year

186 (69.7)

42 (10-103)

0.078

   > 95% in first year

81 (30.3)

58 (22-127)

 

Methadone maintenance

   

   No

160 (59.9)

38 (11-90)

0.003

   Yes

107 (40.1)

60 (20-144)

 

Daily cocaine use1

   

   No

175 (65.5)

59 (13-126)

0.045

   Yes

92 (34.5)

34 (12-92)

 

Daily heroin use1

   

   No

196 (73.4)

47 (13-104)

0.658

   Yes

71 (26.6)

43 (14-116)

 

PI2 in first ART regimen

   

   No

155 (58.1)

44 (14-105)

0.975

   Yes

112 (41.9)

58 (12-111)

 
  1. 1. Refers to the six-month period prior to baseline
  2. 2. Protease inhibitor
  3. 3. Inter-quartile range. Physician experience was defined as per 100 HIV-infected patients previously treated by that physician at the time each participant initiated ART.